Selected research
Market Structure
Global Megestrol Acetate (Megace) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Megestrol Acetate (Megace) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Megestrol Acetate (Megace) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Megestrol Acetate (Megace) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Megestrol Acetate (Megace) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Megestrol Acetate (Megace) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Megestrol Acetate (Megace) include Actiza Pharmaceutical, Apotex Corporation, Breckenridge Pharmaceutical, Hikma (West-ward Pharm, Roxane Labs..), Hi-tech Pharmacal (Akorn), Morton Grove Pharmaceutical, Par Pharmaceutical (Endo International), TWi Pharmaceuticals and Jiangsu Nhwa Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Megestrol Acetate (Megace) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Megestrol Acetate (Megace) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Megestrol Acetate (Megace) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Megestrol Acetate (Megace) market size, projected growth trends, production technologies, key applications, and end-use industries.
Megestrol Acetate (Megace) Segment by Company
Actiza Pharmaceutical
Apotex Corporation
Breckenridge Pharmaceutical
Hikma (West-ward Pharm, Roxane Labs..)
Hi-tech Pharmacal (Akorn)
Morton Grove Pharmaceutical
Par Pharmaceutical (Endo International)
TWi Pharmaceuticals
Jiangsu Nhwa Pharmaceutical
Nanjing Cuccess Pharmaceutical
Qingdao Guohai Biological Pharmaceutical
Teva Pharmaceuticals
Grand Deten Pharmaceutical
Xianju pharma
Megestrol Acetate (Megace) Segment by Type
Suspension
Tablets
Megestrol Acetate (Megace) Segment by Application
Hospital
Clinic
Other
Megestrol Acetate (Megace) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Megestrol Acetate (Megace) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Megestrol Acetate (Megace) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Megestrol Acetate (Megace).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Megestrol Acetate (Megace) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Megestrol Acetate (Megace) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Megestrol Acetate (Megace) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Megestrol Acetate (Megace) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Suspension
- Tablets
Applications
- Hospital
- Clinic
- Other
Companies covered
- Actiza Pharmaceutical
- Apotex Corporation
- Breckenridge Pharmaceutical
- Hikma (West-ward Pharm, Roxane Labs..)
- Hi-tech Pharmacal (Akorn)
- Morton Grove Pharmaceutical
- Par Pharmaceutical (Endo International)
- TWi Pharmaceuticals
- Jiangsu Nhwa Pharmaceutical
- Nanjing Cuccess Pharmaceutical
- Qingdao Guohai Biological Pharmaceutical
- Teva Pharmaceuticals
- Grand Deten Pharmaceutical
- Xianju pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Megestrol Acetate (Megace) Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Megestrol Acetate (Megace) Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Megestrol Acetate (Megace) Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Megestrol Acetate (Megace) Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Megestrol Acetate (Megace) Market Dynamics
- 2.1 Megestrol Acetate (Megace) Industry Trends
- 2.2 Megestrol Acetate (Megace) Industry Drivers
- 2.3 Megestrol Acetate (Megace) Industry Opportunities and Challenges
- 2.4 Megestrol Acetate (Megace) Industry Restraints
3 Megestrol Acetate (Megace) Market by Manufacturers
- 3.1 Global Megestrol Acetate (Megace) Revenue by Manufacturers (2021-2026)
- 3.2 Global Megestrol Acetate (Megace) Sales by Manufacturers (2021-2026)
- 3.3 Global Megestrol Acetate (Megace) Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Megestrol Acetate (Megace) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Megestrol Acetate (Megace) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Megestrol Acetate (Megace) Manufacturers, Product Type & Application
- 3.7 Global Megestrol Acetate (Megace) Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Megestrol Acetate (Megace) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Megestrol Acetate (Megace) Players Market Share by Revenue in 2025
- 3.8.3 2025 Megestrol Acetate (Megace) Tier 1, Tier 2, and Tier 3
4 Megestrol Acetate (Megace) Market by Type
- 4.1 Megestrol Acetate (Megace) Type Introduction
- 4.1.1 Suspension
- 4.1.2 Tablets
- 4.2 Global Megestrol Acetate (Megace) Sales by Type
- 4.2.1 Global Megestrol Acetate (Megace) Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Megestrol Acetate (Megace) Sales by Type (2021-2032)
- 4.2.3 Global Megestrol Acetate (Megace) Sales Market Share by Type (2021-2032)
- 4.3 Global Megestrol Acetate (Megace) Revenue by Type
- 4.3.1 Global Megestrol Acetate (Megace) Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Megestrol Acetate (Megace) Revenue by Type (2021-2032)
- 4.3.3 Global Megestrol Acetate (Megace) Revenue Market Share by Type (2021-2032)
5 Megestrol Acetate (Megace) Market by Application
- 5.1 Megestrol Acetate (Megace) Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Megestrol Acetate (Megace) Sales by Application
- 5.2.1 Global Megestrol Acetate (Megace) Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Megestrol Acetate (Megace) Sales by Application (2021-2032)
- 5.2.3 Global Megestrol Acetate (Megace) Sales Market Share by Application (2021-2032)
- 5.3 Global Megestrol Acetate (Megace) Revenue by Application
- 5.3.1 Global Megestrol Acetate (Megace) Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Megestrol Acetate (Megace) Revenue by Application (2021-2032)
- 5.3.3 Global Megestrol Acetate (Megace) Revenue Market Share by Application (2021-2032)
6 Global Megestrol Acetate (Megace) Sales by Region
- 6.1 Global Megestrol Acetate (Megace) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Megestrol Acetate (Megace) Sales by Region (2021-2032)
- 6.2.1 Global Megestrol Acetate (Megace) Sales by Region (2021-2026)
- 6.2.2 Global Megestrol Acetate (Megace) Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Megestrol Acetate (Megace) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Megestrol Acetate (Megace) Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Megestrol Acetate (Megace) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Megestrol Acetate (Megace) Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Megestrol Acetate (Megace) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Megestrol Acetate (Megace) Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Megestrol Acetate (Megace) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Megestrol Acetate (Megace) Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Megestrol Acetate (Megace) Revenue by Region
- 7.1 Global Megestrol Acetate (Megace) Revenue by Region
- 7.1.1 Global Megestrol Acetate (Megace) Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Megestrol Acetate (Megace) Revenue by Region (2021-2026)
- 7.1.3 Global Megestrol Acetate (Megace) Revenue by Region (2027-2032)
- 7.1.4 Global Megestrol Acetate (Megace) Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Megestrol Acetate (Megace) Revenue (2021-2032)
- 7.2.2 North America Megestrol Acetate (Megace) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Megestrol Acetate (Megace) Revenue (2021-2032)
- 7.3.2 Europe Megestrol Acetate (Megace) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Megestrol Acetate (Megace) Revenue (2021-2032)
- 7.4.2 Asia-Pacific Megestrol Acetate (Megace) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Megestrol Acetate (Megace) Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Megestrol Acetate (Megace) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Actiza Pharmaceutical
- 8.1.1 Actiza Pharmaceutical Company Information
- 8.1.2 Actiza Pharmaceutical Business Overview
- 8.1.3 Actiza Pharmaceutical Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Actiza Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 8.1.5 Actiza Pharmaceutical Recent Developments
- 8.2 Apotex Corporation
- 8.2.1 Apotex Corporation Company Information
- 8.2.2 Apotex Corporation Business Overview
- 8.2.3 Apotex Corporation Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Apotex Corporation Megestrol Acetate (Megace) Product Portfolio
- 8.2.5 Apotex Corporation Recent Developments
- 8.3 Breckenridge Pharmaceutical
- 8.3.1 Breckenridge Pharmaceutical Company Information
- 8.3.2 Breckenridge Pharmaceutical Business Overview
- 8.3.3 Breckenridge Pharmaceutical Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Breckenridge Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 8.3.5 Breckenridge Pharmaceutical Recent Developments
- 8.4 Hikma (West-ward Pharm, Roxane Labs..)
- 8.4.1 Hikma (West-ward Pharm, Roxane Labs..) Company Information
- 8.4.2 Hikma (West-ward Pharm, Roxane Labs..) Business Overview
- 8.4.3 Hikma (West-ward Pharm, Roxane Labs..) Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Hikma (West-ward Pharm, Roxane Labs..) Megestrol Acetate (Megace) Product Portfolio
- 8.4.5 Hikma (West-ward Pharm, Roxane Labs..) Recent Developments
- 8.5 Hi-tech Pharmacal (Akorn)
- 8.5.1 Hi-tech Pharmacal (Akorn) Company Information
- 8.5.2 Hi-tech Pharmacal (Akorn) Business Overview
- 8.5.3 Hi-tech Pharmacal (Akorn) Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Hi-tech Pharmacal (Akorn) Megestrol Acetate (Megace) Product Portfolio
- 8.5.5 Hi-tech Pharmacal (Akorn) Recent Developments
- 8.6 Morton Grove Pharmaceutical
- 8.6.1 Morton Grove Pharmaceutical Company Information
- 8.6.2 Morton Grove Pharmaceutical Business Overview
- 8.6.3 Morton Grove Pharmaceutical Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Morton Grove Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 8.6.5 Morton Grove Pharmaceutical Recent Developments
- 8.7 Par Pharmaceutical (Endo International)
- 8.7.1 Par Pharmaceutical (Endo International) Company Information
- 8.7.2 Par Pharmaceutical (Endo International) Business Overview
- 8.7.3 Par Pharmaceutical (Endo International) Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Par Pharmaceutical (Endo International) Megestrol Acetate (Megace) Product Portfolio
- 8.7.5 Par Pharmaceutical (Endo International) Recent Developments
- 8.8 TWi Pharmaceuticals
- 8.8.1 TWi Pharmaceuticals Company Information
- 8.8.2 TWi Pharmaceuticals Business Overview
- 8.8.3 TWi Pharmaceuticals Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 TWi Pharmaceuticals Megestrol Acetate (Megace) Product Portfolio
- 8.8.5 TWi Pharmaceuticals Recent Developments
- 8.9 Jiangsu Nhwa Pharmaceutical
- 8.9.1 Jiangsu Nhwa Pharmaceutical Company Information
- 8.9.2 Jiangsu Nhwa Pharmaceutical Business Overview
- 8.9.3 Jiangsu Nhwa Pharmaceutical Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Jiangsu Nhwa Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 8.9.5 Jiangsu Nhwa Pharmaceutical Recent Developments
- 8.10 Nanjing Cuccess Pharmaceutical
- 8.10.1 Nanjing Cuccess Pharmaceutical Company Information
- 8.10.2 Nanjing Cuccess Pharmaceutical Business Overview
- 8.10.3 Nanjing Cuccess Pharmaceutical Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Nanjing Cuccess Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 8.10.5 Nanjing Cuccess Pharmaceutical Recent Developments
- 8.11 Qingdao Guohai Biological Pharmaceutical
- 8.11.1 Qingdao Guohai Biological Pharmaceutical Company Information
- 8.11.2 Qingdao Guohai Biological Pharmaceutical Business Overview
- 8.11.3 Qingdao Guohai Biological Pharmaceutical Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Qingdao Guohai Biological Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 8.11.5 Qingdao Guohai Biological Pharmaceutical Recent Developments
- 8.12 Teva Pharmaceuticals
- 8.12.1 Teva Pharmaceuticals Company Information
- 8.12.2 Teva Pharmaceuticals Business Overview
- 8.12.3 Teva Pharmaceuticals Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Teva Pharmaceuticals Megestrol Acetate (Megace) Product Portfolio
- 8.12.5 Teva Pharmaceuticals Recent Developments
- 8.13 Grand Deten Pharmaceutical
- 8.13.1 Grand Deten Pharmaceutical Company Information
- 8.13.2 Grand Deten Pharmaceutical Business Overview
- 8.13.3 Grand Deten Pharmaceutical Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Grand Deten Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 8.13.5 Grand Deten Pharmaceutical Recent Developments
- 8.14 Xianju pharma
- 8.14.1 Xianju pharma Company Information
- 8.14.2 Xianju pharma Business Overview
- 8.14.3 Xianju pharma Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Xianju pharma Megestrol Acetate (Megace) Product Portfolio
- 8.14.5 Xianju pharma Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Megestrol Acetate (Megace) Value Chain Analysis
- 9.1.1 Megestrol Acetate (Megace) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Megestrol Acetate (Megace) Production Mode & Process
- 9.2 Megestrol Acetate (Megace) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Megestrol Acetate (Megace) Distributors
- 9.2.3 Megestrol Acetate (Megace) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst